Plano Matthew T. - 26 May 2022 Form 3 Insider Report for ABIOMED INC

Role
VP, GLOBAL OPERATIONS
Signature
/s/ Marc A. Began (by power of attorney)
Issuer symbol
N/A
Transactions as of
26 May 2022
Net transactions value
$0
Form type
3
Filing time
01 Jun 2022, 18:26:49 UTC
Next filing
12 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NASD Common Stock $.01 par value 9,642 26 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NASD Stock Option (Right to Buy) 26 May 2022 Common Stock 2,000 $381.97 Direct F1, F2
holding NASD Stock Option (Right to Buy) 26 May 2022 Common Stock 5,000 $266.39 Direct F1, F2
holding NASD Stock Option (Right to Buy) 26 May 2022 Common Stock 2,765 $223.90 Direct F1, F2
holding NASD Stock Option (Right to Buy) 26 May 2022 Common Stock 2,765 $283.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F2 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 2